Hepatobiliary diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 20 years old and elder (regardless of gender) 2. Patient who undergone hepatic resection for hepatobiliary cancer (regrdless of operative procedure, range of hepatectomy and peimary disease) 3. patient who accept entry to this study with free will after sufficient exposition
Exclusion criteria
Exclusion criteria: 1. Severe liver dysfunction or severe renal dysfunction 2. Uncontrollable diabetes mellitus 3. Pregnancy or possibility of being pregnant 4. Lactating patient 5. Patient who received another test agent or investigational agent within three months prior to agreement for this study 6. Patient who require combined other organ resection (Stomach, Colon, Lung and so on) 7. Patient who required biliary tract reconstruction 8. Patient who required emergency surgery (HCC rupture) 9. Patient who is considered as inadequate by principal investigator of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR40 of postoperative day 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. QoR40 except postoperative day3 2. Postoperative complications (Clavien-Dindo score) 3. Wound pain (NRS) 4. Dietary intake 5. The number of steps taken 6. Inflammatory response (WBC, CRP, neutrophils, lymphocyte, IFN-gamma, IL-6, TNF-arpha) 7. Live functions (T-BIL, AST, ALT, ALP, Albumin, thrombocyte, PT, ICG) 8. Reactive oxygen value (urinary 8-OHdG) 9. adverse event 10. time of inhalation of hydrogen gas | — |
Contacts
Kansai Medical University